Home » Authors » Mark Lawson

Articles by Mark Lawson

Amrad Reports Positive AM336 Trial Results, Raises A$15.5M

March 6, 2002

Amrad Reports Positive AM336 Trial Results, Raises A$15.5M

March 6, 2002

Australian Researchers Isolate Gene Implicated In Hay Fever

Feb. 20, 2002

Australian Researchers Isolate Gene Implicated In Hay Fever

Feb. 20, 2002

Metabolic Eyeing Phase IIb Trial In Obesity After Positive IIa Study

Feb. 13, 2002

Metabolic Eyeing Phase IIb Trial In Obesity After Positive IIa Study

Feb. 13, 2002

Biota Purchases U.S. Company With Antivirals Program For $8M

May 30, 2001

Biota Purchases U.S. Company With Antivirals Program For $8M

May 30, 2001

Rothschild Planning New Fund For Australian Biotech Firms

May 16, 2001

Rothschild Planning New Fund For Australian Biotech Firms

May 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 22, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 21, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...
Medtronic receives CE mark for next generation Endoflip system
BioWorld MedTech
Medtronic plc obtained a CE mark for its next generation Endoflip 300 system which measures pressure and dimensions in the esophagus and pylorus, in adults. The...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.